Terrific find on the statistical level. It's completely true. Read an article that cited 2,000 opportunities are sent to a big pharma for consideration every year. And based on your find, it certainly shows the level of seriousness and impressive work of the IPIX team. Complete trials sign partnerships, that's how the industry works. And here we go straight into 4 stage 2 trials revealing in the next 2 weeks and coming months. The question is are you positioned to benefit. If you think .74 is going to remain forever than you got something coming to you. ipix has the potential to end 2017 $25 plus. It does happen in biotech and data doesn't lie.